We are live on
!
Find out more
CCC
Cincinnati Casualty Company Portfolio holdings
AUM
$191M
1-Year Est. Return
17.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.01%
1 Year Est. Return
+17.51%
3 Year Est. Return
+50.54%
5 Year Est. Return
+61.73%
10 Year Est. Return
+245.25%
AUM
$191M
AUM Growth
-$5.61M
(-2.8%)
Cap. Flow
-$632K
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
79.95%
Holding
25
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$5.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$5.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 32.66% |
| 2 | Technology | 26.05% |
| 3 | Financials | 10.1% |
| 4 | Energy | 8.75% |
| 5 | Utilities | 7.2% |
No holdings matched the selected filter criteria.
Similar funds
PB
GC
PSU
AGA
CVSC
TA
KWM
SCGDR
Cincinnati Casualty Company's Q1 2026 Portfolio in Review
As of Q1 2026, Cincinnati Casualty Company held 25 positions worth $191M, down 2.8% from $197M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Cincinnati Casualty Company's Q1 2026 filing shows 1 new and 1 closed positions. Its largest new stake was Thermo Fisher Scientific: 9,682 shares worth $4.76M. The largest sale was Pfizer, an estimated $5.89M.
By sector, the portfolio is most concentrated in Industrials at 33% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
- Cincinnati Casualty Company's largest Q1 2026 buy was Thermo Fisher Scientific: 9,682 shares worth $4.76M.
- Cincinnati Casualty Company fully exited Pfizer in Q1 2026, selling an estimated $5.89M.
- Cincinnati Casualty Company's ten largest holdings make up 80% of its $191M portfolio in Q1 2026.
- Cincinnati Casualty Company opened 1 new position and closed 1 in Q1 2026.
- Cincinnati Casualty Company's portfolio value fell 2.8% quarter-over-quarter to $191M.
Based on Cincinnati Casualty Company's 13F filing for Q1 2026, filed 11 May 2026.